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Background: Acute pancreatitis may be caused by a myriad of factors, hypercalcemia
secondary to hyperparathyroidism, albeit is a rare cause of acute pancreatitis but not
unheard of. If the underlying cause of acute pancreatitis is diagnosed, goal-directed
management becomes possible, reducing morbidity and mortality. Though acute
pancreatitis on its own presents significant mortality, hypercalcemia, especially detected
late, augments this. 
Case Report: We report a case of acute pancreatitis secondary to hyperparathyroidism.
The patient was undiagnosed at the time of admission and presented with non-specific
gastrointestinal symptoms. After admission, he developed multi-organ dysfunction and
was managed by intensive care. The patient died within hours of admission despite our
best efforts. Diagnosis of acute pancreatitis secondary to hyperparathyroidism was
suspected on the basis of hypercalcemia, confirmed by a posthumous result of a raised
parathyroid hormone assay.
Conclusion: When a patient is admitted in the emergency department with a suspicion of
acute pancreatitis, serum calcium levels and its reporting should be expedited to as early
as possible. Hypercalcemia in the setting of acute pancreatitis merits a multidisciplinary
approach and expedited parathyroid hormone levels sent with a high suspicion of long-
standing untreated hyperparathyroidism. Hyperparathyroidism is a cause of silent
hypercalcemia and can be lethal if not diagnosed in time. 
Keywords: Pancreatitis, hyperparathyrpidism, hypercalcemia, management
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secondary pancreatitis is a rare disease
entity, with approximately 2.5% of patients
presenting with pancreatitis being diagnosed
with hyperparathyroidism.
doi: 
10.5281/zenodo.3595075
ABSTRACT
INTRODUCTION
Acute pancreatitis has an incidence ranging from 4.5-
79.8 per 100,000 per year worldwide. It can have
serious complications in up to 20-30% of presentations
with a mortality figure of up to 1.62 per 100,000 cases
worldwide. It shares a decent share of annual
admissions in the general surgery and
gastroenterology services. Causes include alcohol,
gallstone disease, abdominal surgery or blunt trauma,
drug-induced, hypertriglyceridemia, infection, cancer,
post-ERCP and hypercalcemia amongst others. About
half the cases of all acute pancreatitis are caused by
gallstones, followed by alcohol, usually binge drinking.
Acute pancreatitis can be managed without any long
term complications with immediate hospitalization and
admission and appropriate care based on severity,
whether in the ward or in the intensive care unit.
Hyperparathyroidism leading to hypercalcemia and 
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However, patients with hyperparathyroidism may have a
pancreatic disease with an incidence of about 1.5%-13%.
The data available is variable, and the question about
disease severity remains dependent on which was
discovered first the hypercalcemia or pancreatitis.
Hypercalcemia though a rare finding in its own, could be
caused by various etiologies, hyperparathyroidism,
multiple myeloma, malignancy and sarcoidosis being
some of the common causes of long-standing and
possibly silent hypercalcemia.
Hypercalcemia may present as chronic pancreatitis or
acute pancreatitis, and in cases with acute pancreatitis,
the disease severity is likely to be associated with greater 
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morbidity and mortality as the long-standing
hypercalcemia is more likely to have already affected
other organ systems, and the usual treatment for
pancreatitis might fall short. On the basis of severity,
hypercalcemia is classified into mild (10-12 mg/dl),
moderate (12-14mg/dl) and severe (>14 mg/dl).
We present an unusual presentation of
hyperparathyroidism presenting as acute pancreatitis
culminating in multiple organ failure and death of the
patient.
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We present the case of a 42-year-old hypertensive
male, who presented in the emergency room during the
night with complaints of mild epigastric pain for five
days and three episodes of vomiting over the last 24
hours. His past history was unremarkable. He was
vitally stable, with a blood pressure of 130/80 mmHg,
heart rate of 90 beats per minute, respiratory rate of 20
per minute and saturations of 98%. The examination
was only remarkable for tenderness in the epigastric
region, not associated with any guarding or rigidity and
normal bowels sounds. He was started on pain
medications, anti-emetics, ceftriaxone, a proton-pump
inhibitor, and a ringer lactate infusion at 120ml/hr and
admitted with a suspicion of pancreatitis. He was nil per
mouth till further orders. Catheterisation was done to
monitor urine output.Labs, including a complete blood
count (CBC), liver function tests (LFTs), renal function
tests (RFTs) and urine examination were sent at the
time. A chest x-ray was done that did not show any
active pulmonary pathology. An ultrasound was
ordered to be carried out in the morning. His amylase
returned in the morning, which was elevated at 514IU.
However, on repeat examination 6 hours later, his
epigastric tenderness was worsening in severity, and
his chest now had a few scattered rhonchi. His
saturations were dropping to 90% and oxygen at 2
litres per minute via nasal prongs was attached that
promptly corrected the hypoxia, and 1-litre fluid rushed.
His antibiotic was changed from ceftriaxone to
imipenem. The patient was shifted to the ICU for
intensive monitoring, and an ECG was done that
showed poor R-wave progression, and a cardiology
consult was requested. Troponin-I was done, which
was negative. His labs from the night of admission
showed normal LFTs, a raised alkaline phosphatase at
603U/L, RFTs were deranged, with a creatinine of
2.2mg/dL and urea of 56mg/dL, and a creatinine
clearance that was compromised at 46.40, his
medications were adjusted according to renal dosing.
Coagulation profile was unremarkable, and his CBC 
was only remarkable for a platelet count of 120,000 u/L
and a raised WBC count of 14.8 and neutrophilia. LDH
was 720U/L, and Glucose random was 96mg/dL.
Ranson’s score was 1/5.
His serum calcium was sent that returned later in the
afternoon, and an ABG was done that was normal.  An
ultrasound done in the morning after an evening of
admission showed a left renal calculus, mild
abdominopelvic ascites and echogenic debris in the
gallbladder.
At this point, our impression was that he had gallstone
pancreatitis with possible underlying acute on chronic
kidney injury.  He was conscious and alert till late
afternoon. He started becoming slightly confused later in
the evening; however, GCS was 15/15. Calcium returned
at 3:00 P.M. and was 14.8 mg/dL with a normal albumin
level. A parathyroid hormone assay was sent to make a
diagnosis with multiple myeloma in the differentials.
Malignancy and sarcoidosis were lower on the list due to
a normal chest x-ray. The patient was in hypercalcemic
crisis, and 2 l normal saline was rushed, and forced
diuresis was done with 100 mg of furosemide. His urine
output in the last 6 hours was 200 ml. Despite the forced
diuresis his urine output in the anteceding 6 hours only
increased by 250 ml.
Repeat labs at 10:00 P.M. showed calcium of 16.6
mg/dL, LFTs were now deranged with elevated bilirubin,
ALT and AST. His creatinine was now 3.5mg/dL and urea
88mg/dL. Serum electrolytes besides calcium were
normal throughout.
On examination, the patient was not maintaining oxygen
saturations by face mask, was progressively becoming
tachycardic, and his blood pressure which was previously
maintained at 130-140/90-100 had shot up to 160/80. He
was becoming confused and agitated, and his GCS had
started to drop. He was intubated at 12:00 A.M., within 24
hours of his admission and kept on SIMV mode with an
FIO of 40%; Propofol and Atrelax infusions were used for
sedation and paralysis.
His chest had increased rhonchi and abdomen was
slightly distended. A diagnosis of multi-organ dysfunction
was made, and forced diuresis was continued. A repeat
ABG before intubation showed metabolic acidosis with
partial respiratory compensation.  Despite all efforts, early
in the morning, he started to decompensate, was not
maintaining his blood pressures and inotropic support
was started. His urine output overnight while on
mechanical ventilation, had only increased by 150 ml.
Nephrology was consulted for urgent dialysis; however,
the patient, even on maximum ventilatory & ionotropic
supports, couldn't maintain his saturations and pressures 
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and went into cardiac arrest. Despite extensive
cardiopulmonary resuscitation, he did not revive. His
parathyroid hormone assay returned shortly after and
was 1145.4 pg. / ml. (Normal reference range: 15-68.3
pg. / ml).
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Most of the serum calcium in the body is bound to
albumin and rest is in ionized form. The level of serum
calcium in varies with the serum albumin level. The
severity of the disease depends on the level of calcium.
Most of the cases with mild hypercalcemia remain
asymptomatic. The most frequent gastrointestinal
manifestations of hypercalcemia are constipation,
heartburn, nausea & loss of appetite. Vague abdominal
pain is also a common gastrointestinal manifestation of
hypercalcemia. Patients may have oliguria; a renal
failure in such patients can be treated with correction of
serum calcium levels and repeated hemodialysis.
Chronic hypercalcemia can lead to the formation of
renal stones, as was with our patient.
of multi-organ dysfunction syndrome (MODS) when we
received him, and the MODS accelerated exponentially in
the 24 hours that he was in the ICU leading to his death.
DISCUSSION
Neuropsychiatric manifestations of hypercalcemia
manifest as alternation in cognition and can progress to
stupor and coma if untreated. Abnormally high serum
calcium cause cardiac arrhythmias, shortens the QT
interval and predisposes the patient to sudden cardiac
death in some instances. The diagnosis of primary
hyperparathyroidism is made on the basis of
persistently elevated serum calcium levels in the
presence of abnormally high parathyroid hormone
levels.
Hypercalcemic crisis is a medical emergency that could
present with gastrointestinal, renal and neurological
involvement presenting as a diagnostic challenge due
to the differential list that is exhaustive; and has been
attributed to high mortality, which was nearly universal
up until the late 1950s and 60s. A recent study showed
that their patients with hypercalcemia had a 33.3%
mortality rate. Other studies show variable mortality
some as low as 14%. However, the cornerstone of
management remains forced diuresis along with
bisphosphonate therapy, that might decrease the days
it takes to reach eucalcemia to 4-5 days with
bisphosphonates versus an average of 14-15 days
without bisphosphonates- and expedited
parathryoidectomy. The mortality seems to be higher in
those with confusion and oliguria developing.
Unfortunately for our patient, we presume he had long-
standing hypercalcemia that developed into a
hypercalcemic crisis with pancreatitis; developing and
augmenting rapidly in severity for the five days before
he presented to us, and was already at the beginning 
[10]
[11]
[12]
[13]
[14]
[15]
The disease is rapidly progressing, and there is the
involvement of multiple systems. The mortality in
pancreatitis secondary to hyperparathyroidism varies
from 14-30%, and it becomes higher when the central
nervous system and renal system is involved.
In our patient, the delay of a few hours in sending serum
calcium from presentation might have affected the
outcome, but marginally. However, the role of expediting
serum calcium levels in a patient with pancreatitis at
presentation or a presumed diagnosis cannot be stressed
upon more, knowing that in a rare and small percentage
of patients pancreatitis could be secondary to
hypercalcemia which would effectively change
management goals largely.
Waiting for 48 hours to send serum calcium might be
devastating, and from our experience, patients who
present with suspicion of pancreatitis should have serum
calcium sent at the time of workup for suspected
pancreatitis to avoid unnecessary delays. Further,
expediting parathyroid hormone levels in a patient with
hypercalcemia and pancreatitis could lead to an urgent
parathyroidectomy that might change the outcomes in
such patients.
[10-11,15]
CONCLUSION
When a patient is admitted with a suspicion of acute
pancreatitis, serum calcium should be sent on an
emergent basis to rule out hypercalcemia as a cause.
The management of pancreatitis depends on identifying
the underlying cause; hyperparathyroidism should be
investigated if hypercalcemia is found. Multidisciplinary
teams should be involved in the treatment of such
patients, and if merited, parathyroidectomy should be
done to normalize calcium.
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